FINWIRES · TerminalLIVE
FINWIRES

Update: Truist Financial to Sell $5.5 Billion of Regional Acceptance Auto Loans to Apollo

By

(Updates the headline and adds details in the second and last paragraphs.)

Truist Financial (TFC) said Tuesday it agreed to sell $5.5 billion of auto loans representing substantially all the assets of its Regional Acceptance unit.

The buyer is Apollo Global Management (APO), Bloomberg News reported Tuesday, citing people familiar with the matter.

Truist said the deal is expected to close in late Q3 or early Q4, and generate about $5.2 billion of net proceeds along with a $535 million release of loan-loss reserves.

The sale is expected to increase its equity Tier 1 capital ratio by about 22 basis points and reduce non-performing loans by more than 10 basis points as of June 30, the company said.

It is also expected to reduce annual net charge-offs by about 10 basis points, the company added.

Truist said its Q3 and full-year 2026 outlook remains unchanged, excluding the impact of the strategic actions.

The company said it expects the actions to modestly increase earnings and return on tangible common equity in 2027.

Truist Financial and Apollo Global Management did not immediately respond to requests for comment from.

Price: $51.05, Change: $+0.95, Percent Change: +1.89%

What else is happening in Wire?

Wire

Veea, NovaGen Sign Term Sheet for Potential $750 Million Combination

Veea (VEEA) and NovaGen Group signed a term sheet to merge in a deal that values the new entity at $750 million, and GeoNova Capital also signed a term sheet to invest $10 million in the combined company as a cornerstone investor.Veea said Monday the value of the combined company was based on management's internal projections and an independent assessment.The potential merger remains subject to definitive documentation and closing conditions, with a final agreement expected in the coming weeks, the companies said.The companies also announced plans to launch NovaGen Health Networks, a connected health platform combining Veea's edge computing and cybersecurity technology with NovaGen's cellular reprogramming and clinical services. Initial deployments are set to begin at NovaGen clinics and partner hospitals in Q4.Veea is headquartered in New York, NovaGen is based in Amsterdam, and GeoNova Capital is in the United Arab Emirates.Veea shares rose 59% in after-hours trading.

$VEEA
Wire

Contineum Therapeutics Says Phase 2 Major Depressive Disorder Study Fails to Meet Primary Efficacy Endpoint

Contineum Therapeutics (CTNM) said late Monday the phase 2 MOONLIGHT-1 trial of JNJ-5120/PIPE-307 for the treatment of major depressive disorder did not meet its primary efficacy endpoint.JNJ-5120/PIPE-307 is being developed by Johnson & Johnson (JNJ) under a global license and development agreement, the company noted.The study evaluated improvement from baseline in the Montgomery-Asberg Depression Rating Scale total score at Day 5 compared with placebo, the company said, adding that the treatment was well tolerated and showed no new safety signals.Johnson & Johnson is continuing to review the trial data, including prespecified exploratory endpoints, to determine next steps for the program, according to a statement.

$CTNM$JNJ
Wire

Market Chatter: OpenAI Acquires Camera Startup Glass Imaging

Microsoft-backed (MSFT) OpenAI quietly acquired Glass Imaging, a startup developing AI-powered smartphone camera technology aimed at matching DSLR image quality, The Wall Street Journal reported Monday, citing people familiar with the matter.The deal valued Glass Imaging at more than $300 million, some of the people said, according to the report. OpenAI's exact plans for Glass Imaging are not clear, the report added.OpenAI and Glass Imaging did not immediately respond to requests for comment from.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $506.92, Change: $+11.29, Percent Change: +2.28%

$MSFT